CalciMedica Inc
NASDAQ:CALC
Income Statement
Earnings Waterfall
CalciMedica Inc
Income Statement
CalciMedica Inc
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(35)
|
(36)
|
(36)
|
(35)
|
(35)
|
(35)
|
(33)
|
(48)
|
(47)
|
(41)
|
(38)
|
(21)
|
(21)
|
(22)
|
(24)
|
(25)
|
(25)
|
(25)
|
|
| Selling, General & Administrative |
(14)
|
(16)
|
(17)
|
(16)
|
(17)
|
(17)
|
(19)
|
(31)
|
(29)
|
(27)
|
(22)
|
(9)
|
(9)
|
(9)
|
(10)
|
(9)
|
(9)
|
(9)
|
|
| Research & Development |
(21)
|
(20)
|
(19)
|
(19)
|
(18)
|
(18)
|
(14)
|
(15)
|
(14)
|
(14)
|
(16)
|
(12)
|
(13)
|
(13)
|
(14)
|
(16)
|
(16)
|
(16)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(35)
N/A
|
(36)
-3%
|
(36)
+1%
|
(35)
+4%
|
(35)
-2%
|
(35)
+1%
|
(33)
+4%
|
(48)
-45%
|
(47)
+4%
|
(41)
+11%
|
(38)
+8%
|
(21)
+44%
|
(21)
+0%
|
(22)
-4%
|
(24)
-8%
|
(25)
-3%
|
(25)
0%
|
(25)
+0%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
4
|
3
|
2
|
4
|
7
|
7
|
9
|
5
|
3
|
1
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(2)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
|
| Pre-Tax Income |
(33)
N/A
|
(36)
-10%
|
(36)
+1%
|
(35)
+4%
|
(35)
-2%
|
(37)
-5%
|
(36)
+3%
|
(45)
-26%
|
(43)
+4%
|
(38)
+12%
|
(34)
+9%
|
(15)
+57%
|
(13)
+16%
|
(14)
-8%
|
(14)
-1%
|
(19)
-38%
|
(21)
-11%
|
(23)
-10%
|
|
| Net Income | |||||||||||||||||||
| Income from Continuing Operations |
(33)
|
(36)
|
(36)
|
(35)
|
(35)
|
(37)
|
(36)
|
(45)
|
(43)
|
(38)
|
(34)
|
(15)
|
(13)
|
(14)
|
(14)
|
(19)
|
(21)
|
(23)
|
|
| Net Income (Common) |
(35)
N/A
|
(36)
-2%
|
(36)
+1%
|
(35)
+4%
|
(35)
-2%
|
(37)
-5%
|
(36)
+3%
|
(45)
-26%
|
(43)
+4%
|
(38)
+12%
|
(34)
+9%
|
(15)
+57%
|
(13)
+16%
|
(14)
-8%
|
(14)
-1%
|
(19)
-38%
|
(21)
-11%
|
(23)
-10%
|
|
| EPS (Diluted) |
-23.45
N/A
|
-23.88
-2%
|
-23.72
+1%
|
-22.56
+5%
|
-22.91
-2%
|
-23.94
-4%
|
-23.27
+3%
|
-54.56
-134%
|
-7.56
+86%
|
-6.63
+12%
|
-7.66
-16%
|
-1.48
+81%
|
-1.13
+24%
|
-1.22
-8%
|
-1.22
N/A
|
-1.33
-9%
|
-1.39
-5%
|
-1.52
-9%
|
|